SLC45A3 and prostate cancer: Also, the chimeric transcript SLC45A3-ELK4, generated by cis-splicing between the adjacent SLC45A3 and ELK4 genes, did not involve DNA rearrangements or trans-splicing and could augment prostate cancer cell proliferation [19].